FDA Center for Veterinary Medicine · Regulatory Update · July 21, 2026
FDA Launches Pilot Program to Incentivize Manufacturing of Animal Drug Products in the U.S.
The FDA Center for Veterinary Medicine launched a pilot program that will prioritize review of animal-drug applications when both the finished product and its active pharmaceutical ingredients are manufactured in the United States. The agency says the program is intended to strengthen supply resilience and reduce the risk of veterinary drug shortages.